BioClinica Acquires Synowledge

September 21, 2015

Applied Clinical Trials

Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events.

BioClinica®, Inc., a clinical trials services and technology provider, announced that it has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market.  Headquartered in Miami, Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events. Synowledge has over 500 globally-located employees. Sankesh Abbhi, founder of Synowledge, will serve as senior vice president and head of global safety and regulatory solutions.

 

Read the full release.

Related Content:

News